Back
PTC Therapeutics Vs. Design Therapeutics Industry Stock Comparison
Sell
29
PTCT
PTC Therapeutics
Last Price:
31.57
Seasonality Move:
-2.02%
Buy
52
DSGN
Design Therapeutics
Last Price:
4.68
Seasonality Move:
-14.99%
Sell
29
PTC Therapeutics (PTCT)
is a Sell
Is PTC Therapeutics a Buy, Sell or Hold?
- The current PTC Therapeutics [PTCT] share price is $31.52. The Score for PTCT is 29, which is 42% below its historic median score of 50, and infers higher risk than normal.
- PTCT is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
52
Design Therapeutics (DSGN)
is a Buy
Is Design Therapeutics a Buy, Sell or Hold?
- The current Design Therapeutics [DSGN] share price is $4.68. The Score for DSGN is 52, which is 4% above its historic median score of 50, and infers lower risk than normal.
- DSGN is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
PTCT Stock Price Chart
What is PTC Therapeutics's stock price today?
-
The PTC Therapeutics share price today is $31.52
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and PTCT is experiencing slight buying pressure.
DSGN Stock Price Chart
What is Design Therapeutics's stock price today?
-
The Design Therapeutics share price today is $4.68
The current trend is moderately bearish and DSGN is experiencing slight buying pressure.
PTCT Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.01 | Sell |
| Relative Strength Index (14 RSI): | 38.97 | Sell |
| Chaikin Money Flow: | 170703 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (31.72 - 34.6) | Sell |
| Bollinger Bands (100): | (30.03 - 36.39) | Sell |
DSGN Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.09 | Buy |
| Relative Strength Index (14 RSI): | 50.53 | Buy |
| Chaikin Money Flow: | 22483 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (4.3 - 4.96) | Buy |
| Bollinger Bands (100): | (3.63 - 4.71) | Buy |
PTCT Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 33.93 | Sell |
| 20-day SMA: | 33.47 | Sell |
| 50-day SMA: | 32.93 | Sell |
| 200-day SMA: | 30.24 | Buy |
| 8-day EMA: | 33.21 | Sell |
| 20-day EMA: | 33.46 | Sell |
| 50-day EMA: | 33.33 | Sell |
| 200-day EMA: | 32.28 | Sell |
DSGN Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 4.75 | Sell |
| 20-day SMA: | 4.7 | Sell |
| 50-day SMA: | 4.39 | Buy |
| 200-day SMA: | 3.45 | Buy |
| 8-day EMA: | 4.76 | Sell |
| 20-day EMA: | 4.71 | Sell |
| 50-day EMA: | 4.48 | Buy |
| 200-day EMA: | 4.09 | Buy |
PTC Therapeutics Earnings Growth & PTCT Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.13 per share, an increase next quarter of $0.67 per share, an increase this year of $0.38 per share, and an increase next year of $0.67 per share.
Design Therapeutics Earnings Growth & DSGN Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.17 per share, a decrease next quarter of $0.04 per share, an increase this year of $0.39 per share, and a decrease next year of $0.26 per share.
PTC Therapeutics Technical Analysis
| Aug 23 | Aug 26 | Aug 27 | Aug 28 | Aug 29 | Aug 30 | Sep 3 | Sep 4 | Sep 5 | Sep 6 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug | Sep | |||||||||
| 23 | 26 | 27 | 28 | 29 | 30 | 03 | 04 | 05 | 06 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Design Therapeutics Technical Analysis
| Aug 23 | Aug 26 | Aug 27 | Aug 28 | Aug 29 | Aug 30 | Sep 3 | Sep 4 | Sep 5 | Sep 6 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug | Sep | |||||||||
| 23 | 26 | 27 | 28 | 29 | 30 | 03 | 04 | 05 | 06 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||